Targeting the EGF Receptor for Ovarian Cancer Therapy


Ovarian carcinoma is the leading cause of death from gynecologic malignancy in the US. Factors such as the molecular heterogeneity of ovarian tumors and frequent diagnosis at advanced stages hamper effective disease treatment. There is growing emphasis on the identification and development of targeted therapies to disrupt molecular pathways in cancer. The… (More)
DOI: 10.1155/2010/414676

3 Figures and Tables


  • Presentations referencing similar topics